Regulatory in brief | opioids, pholcodine, Arthrem

23 September 2020 - Deborah Wilkes

Archived

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has introduced stronger warnings for prescribed and OTC medicines containing opioids, while New Zealand’s Medsafe is to reconsider a recent recommendation for pholcodine and has reached a settlement over Arthrem.

Click tags below for more information on topics:

MHRA Medsafe

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: